IceCure Medical Ltd Sustainability Reports
IceCure Medical Ltd. is a commercial-stage medical device company that develops and markets advanced liquid-nitrogen-based cryoablation systems to destroy benign and cancerous tumors by freezing.
Sector: Manufacturing
Country: Israel
Exchange: Nasdaq
FIGI: BBG001V04FF8
3 reports from 2021 to 2025
Company Profile
IceCure Medical Ltd. is a commercial-stage medical device company that develops and markets advanced liquid-nitrogen-based cryoablation systems to destroy benign and cancerous tumors by freezing.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
